Illinois General Assembly - Bill Status for SB2539
Illinois General Assembly

Previous General Assemblies

 Bill Status of SB2539  102nd General Assembly


Short Description:  CONTROLLED SUBSTANCE-PRESCRIBE

Senate Sponsors
Sen. Don Harmon

Last Action
DateChamber Action
  1/10/2023SenateSession Sine Die

Statutes Amended In Order of Appearance
720 ILCS 570/322 new


Synopsis As Introduced
Amends the Illinois Controlled Substances Act. Provides that a prescriber shall offer a prescription for naloxone hydrochloride, or another similar drug approved by the Food and Drug Administration, under specified circumstances. Provides for educational information to be provided concerning overdose prevention and the use of naloxone hydrochloride. Provides that a prescriber who does not comply with specified requirements shall be subject to administrative sanctions under the appropriate licensing board. Specifies that the provisions do not create a private right of action against a prescriber, and do not limit a prescriber's liability for the negligent failure to diagnose or treat a patient. Provides that these provisions do apply to a patient receiving hospice care in accordance with the Hospice Program Licensing Act. Contains a purpose provision. Effective immediately.

Actions 
DateChamber Action
  2/26/2021SenateFiled with Secretary by Sen. Melinda Bush
  2/26/2021SenateFirst Reading
  2/26/2021SenateReferred to Assignments
  12/31/2022SenateChief Sponsor Changed to Sen. Don Harmon
  1/10/2023SenateSession Sine Die

Back To Top